Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1490

1.

The onset of treatment with the antidepressant desipramine is critical for the emotional consequences of neuropathic pain.

Alba-Delgado C, Llorca-Torralba M, Mico JA, Berrocoso E.

Pain. 2018 Dec;159(12):2606-2619. doi: 10.1097/j.pain.0000000000001372.

PMID:
30130302
2.

Involvement of prelimbic 5-HT7 receptors in the regulation of anxiety-like behaviors in hemiparkinsonian rats.

Du CX, Guo Y, Zhang QJ, Zhang J, Lv SX, Liu J.

Neurol Res. 2018 Oct;40(10):847-855. doi: 10.1080/01616412.2018.1493962. Epub 2018 Jul 10.

PMID:
29989483
3.

Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.

Osland ST, Steeves TD, Pringsheim T.

Cochrane Database Syst Rev. 2018 Jun 26;6:CD007990. doi: 10.1002/14651858.CD007990.pub3. Review.

PMID:
29944175
4.

[Response to serotonergic and noradrenergic antidepressants: a crossover study of fluoxetine and desipramine in patients with first major depression episode].

Ontiveros-Sánchez de la Barquera JA.

Gac Med Mex. 2017 Nov-Dec;153(6):688-694. doi: 10.24875/GMM.17002671. Spanish.

5.

Failure to detect the action of antidepressants in the forced swim test in Swiss mice.

Suman PR, Zerbinatti N, Theindl LC, Domingues K, Lino de Oliveira C.

Acta Neuropsychiatr. 2018 Jun;30(3):158-167. doi: 10.1017/neu.2017.33. Epub 2017 Dec 5.

PMID:
29202894
6.

Depressive-like phenotype induced by prenatal dexamethasone in mice is reversed by desipramine.

Conti M, Spulber S, Raciti M, Ceccatelli S.

Neuropharmacology. 2017 Nov;126:242-249. doi: 10.1016/j.neuropharm.2017.09.015. Epub 2017 Sep 13.

PMID:
28916331
7.

Modulating cancer cell survival by targeting intracellular cholesterol transport.

Kuzu OF, Gowda R, Noory MA, Robertson GP.

Br J Cancer. 2017 Aug 8;117(4):513-524. doi: 10.1038/bjc.2017.200. Epub 2017 Jul 11.

8.

Stimulation of adrenergic activity by desipramine enhances hematopoietic stem and progenitor cell mobilization along with G-CSF in multiple myeloma: A pilot study.

Shastri A, Budhathoki A, Barta SK, Kornblum N, Derman O, Battini R, Raghupathy R, Verma AK, Frenette PS, Braunschweig I, Janakiram M.

Am J Hematol. 2017 Oct;92(10):1047-1051. doi: 10.1002/ajh.24843. Epub 2017 Jul 29.

9.

A Comparison of Sexual Side Effects of Antidepressants With and Without Naltrexone.

Thapa M, Petrakis I, Ralevski E.

J Dual Diagn. 2017 Jul-Sep;13(3):230-235. doi: 10.1080/15504263.2017.1326650. Epub 2017 May 8.

PMID:
28481169
10.

The hippocampus and dorsal raphe nucleus are key brain areas associated with the antidepressant effects of lithium augmentation of desipramine.

Cussotto S, Cryan JF, O'Leary OF.

Neurosci Lett. 2017 May 1;648:14-20. doi: 10.1016/j.neulet.2017.03.040. Epub 2017 Mar 27.

PMID:
28351776
11.

Hepatic inflammatory cytokine production can be regulated by modulating sphingomyelinase and ceramide synthase 6.

Kim MH, Ahn HK, Lee EJ, Kim SJ, Kim YR, Park JW, Park WJ.

Int J Mol Med. 2017 Feb;39(2):453-462. doi: 10.3892/ijmm.2016.2835. Epub 2016 Dec 22.

PMID:
28035360
12.

Role of Prefrontal Serotonergic and Dopaminergic Systems in Encounter-Induced Hyperactivity in Methamphetamine-Sensitized Mice.

Tanaka T, Ago Y, Umehara C, Imoto E, Hasebe S, Hashimoto H, Takuma K, Matsuda T.

Int J Neuropsychopharmacol. 2017 May 1;20(5):410-421. doi: 10.1093/ijnp/pyw115.

13.

The expression of plasticity-related genes in an acute model of stress is modulated by chronic desipramine in a time-dependent manner within medial prefrontal cortex.

Nava N, Treccani G, Müller HK, Popoli M, Wegener G, Elfving B.

Eur Neuropsychopharmacol. 2017 Jan;27(1):19-28. doi: 10.1016/j.euroneuro.2016.11.010. Epub 2016 Nov 24.

PMID:
27890541
14.

Ontogeny of Norepinephrine Transporter Expression and Antidepressant-Like Response to Desipramine in Wild-Type and Serotonin Transporter Mutant Mice.

Mitchell NC, Bowman MA, Gould GG, Koek W, Daws LC.

J Pharmacol Exp Ther. 2017 Jan;360(1):84-94. Epub 2016 Nov 9.

15.

Prophylactic treatment with the tricyclic antidepressant desipramine prevents development of paclitaxel-induced neuropathic pain through activation of endogenous analgesic systems.

Deng L, Lee WH, Xu Z, Makriyannis A, Hohmann AG.

Pharmacol Res. 2016 Dec;114:75-89. doi: 10.1016/j.phrs.2016.10.007. Epub 2016 Oct 20.

16.

Desipramine improves upper airway collapsibility and reduces OSA severity in patients with minimal muscle compensation.

Taranto-Montemurro L, Sands SA, Edwards BA, Azarbarzin A, Marques M, de Melo C, Eckert DJ, White DP, Wellman A.

Eur Respir J. 2016 Nov;48(5):1340-1350. doi: 10.1183/13993003.00823-2016. Epub 2016 Oct 6.

17.

Tardive tachypnea.

Varrone J, Lavoie K, Manthous CA.

Intensive Care Med. 2016 Dec;42(12):2126. doi: 10.1007/s00134-016-4555-5. Epub 2016 Oct 3. No abstract available.

PMID:
27699455
18.

Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.

Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, Coghill D, Zhang Y, Hazell P, Leucht S, Cuijpers P, Pu J, Cohen D, Ravindran AV, Liu Y, Michael KD, Yang L, Liu L, Xie P.

Lancet. 2016 Aug 27;388(10047):881-90. doi: 10.1016/S0140-6736(16)30385-3. Epub 2016 Jun 8.

PMID:
27289172
19.

Desipramine Increases Genioglossus Activity and Reduces Upper Airway Collapsibility during Non-REM Sleep in Healthy Subjects.

Taranto-Montemurro L, Edwards BA, Sands SA, Marques M, Eckert DJ, White DP, Wellman A.

Am J Respir Crit Care Med. 2016 Oct 1;194(7):878-885.

20.

Desipramine administered chronically inhibits lipopolysaccharide-stimulated production of IL-1β in the brain and plasma of rats.

Obuchowicz E, Prymus A, Bielecka AM, Drzyzga Ł, Paul-Samojedny M, Kot M, Daniel WA.

Cytokine. 2016 Apr;80:26-34. doi: 10.1016/j.cyto.2015.10.012. Epub 2016 Mar 2.

PMID:
26937856

Supplemental Content

Loading ...
Support Center